Home › Funds › BFSG, LLC › SOLV

BFSG, LLC position in SOLV

SOLVENTUM CORP · Health Care

BFSG, LLC reported holding 85,434 shares of SOLV (SOLVENTUM CORP) in its Q3 2026 13F filing — a position valued at US$7.5M, representing 0.69% of its reported portfolio and ranking #38 among its reported holdings. BFSG, LLC has disclosed SOLV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)85.43K sh
Reported value held$7.53M
Portfolio Weight0.69%
First reportedQ2 2026
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BFSG, LLC's SOLV position evolved

BFSG, LLC first disclosed a stake in SOLV in Q2 2026 at 87,227 shares (US$6.7M). The position peaked in Q3 2026 at 85,434 shares, worth US$7.5M. Across 2 filings, BFSG, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 85,434 shares valued at US$7.5M — a reduction of -1,793 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 87.23K $6.73M New
Q3 2026 85.43K $7.53M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SOLV and 13F data

SOLV (SOLVENTUM CORP) is a Health Care company. 41 other funds we track also report a position in SOLV — the largest reported positions include Independent Franchise Partners LLP (US$1.38B), TRIAN FUND MANAGEMENT, L.P. (US$635.5M), DAVIS SELECTED ADVISERS (US$565.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SOLV

All SOLV fund holders →

FAQ

How long has BFSG, LLC held SOLV?

BFSG, LLC has disclosed SOLV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is BFSG, LLC's current position in SOLV?

As of Q3 2026, BFSG, LLC holds 85.43K shares of SOLV (SOLVENTUM CORP), valued at $7.53M, representing 0.69% of its reported portfolio and ranking #38.

Has BFSG, LLC been buying or selling SOLV?

In the latest 13F filing (Q3 2026), BFSG, LLC reduced its position in SOLV. The position peaked in Q3 2026 at 85.43K shares.

Which other funds hold SOLV?

Other major institutional holders of SOLV include Independent Franchise Partners LLP, TRIAN FUND MANAGEMENT, L.P., DAVIS SELECTED ADVISERS, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.